IRIS
BUGATTI, SERENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.779
EU - Europa 1.216
AS - Asia 770
OC - Oceania 3
SA - Sud America 3
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.775
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.761
CN - Cina 650
IE - Irlanda 456
FI - Finlandia 197
DE - Germania 149
UA - Ucraina 129
IT - Italia 123
SG - Singapore 107
SE - Svezia 77
GB - Regno Unito 31
CA - Canada 18
BE - Belgio 17
FR - Francia 12
RU - Federazione Russa 9
CZ - Repubblica Ceca 6
IN - India 4
LT - Lituania 4
AT - Austria 2
AU - Australia 2
BR - Brasile 2
EU - Europa 2
IL - Israele 2
ZM - Zambia 2
AZ - Azerbaigian 1
CL - Cile 1
ES - Italia 1
GR - Grecia 1
HK - Hong Kong 1
ID - Indonesia 1
IR - Iran 1
JP - Giappone 1
KR - Corea 1
NL - Olanda 1
NZ - Nuova Zelanda 1
RO - Romania 1
TR - Turchia 1
Totale 3.775
Salva come PNG Salva come JPEG
Città #
Dublin 451
Chandler 415
Nanjing 195
Jacksonville 194
Boardman 122
Ashburn 119
Helsinki 111
Princeton 81
Singapore 79
Lawrence 75
Wilmington 74
Nanchang 67
Ann Arbor 64
Beijing 62
New York 62
Shenyang 58
Medford 51
Hebei 50
Shanghai 50
Changsha 44
Jiaxing 36
Milan 31
Hangzhou 23
Pavia 23
Munich 21
Tianjin 19
Piscataway 18
Woodbridge 18
Brussels 17
Seattle 15
Toronto 12
Fairfield 11
Norwalk 11
London 8
Berlin 7
Falkenstein 7
Washington 7
Brno 6
Verona 6
Dallas 5
Los Angeles 5
Taizhou 5
Houston 4
Kunming 4
Menlo Park 4
Sassari 4
Zhengzhou 4
Bollate 3
Falls Church 3
Fort St. James 3
Ningbo 3
Segrate 3
Sona 3
Tappahannock 3
Bad Sobernheim 2
Buffalo 2
Bulgorello 2
Busto Arsizio 2
Chicago 2
Des Moines 2
Florence 2
Frankfurt am Main 2
Fremont 2
Genoa 2
Monza 2
Nanaimo 2
Newark 2
Orange 2
Padova 2
Pune 2
Ramat Gan 2
Rozzano 2
San Francisco 2
Baku 1
Bolzano 1
Borås 1
Brivio 1
Buccinasco 1
Canberra 1
Changchun 1
Chongqing 1
Desio 1
Elk Grove Village 1
Fagnano Olona 1
Fayetteville 1
Fuzhou 1
Gostar 1
Guangzhou 1
Gunzenhausen 1
Haikou 1
Hanover 1
Hengyang 1
Hong Kong 1
Hyderabad 1
Linyi 1
Lungavilla 1
Madrid 1
Messina 1
Montreal 1
Mumbai 1
Totale 2.841
Salva come PNG Salva come JPEG
Nome #
Involvement of subchondral bone marrow in rheumatoid arthritis: lymphoid neogenesis and in situ relationship to subchondral bone marrow osteoclast recruitment. 91
B cells in rheumatoid arthritis: from pathogenic players to disease biomarkers 85
Assessment of synovitis to predict bone erosions in rheumatoid arthritis 82
B cells in rheumatoid arthritis. 79
Anti-neutrophil cytoplasmic antibodies (ANCA) ( Review ) [Anticorpi anticitoplasma dei neutrofili (ANCA)] 74
Ultrasonographic and MRI characterisation of the palindromic phase of rheumatoid arthritis 73
Analysis of the apoliporotein(a) size polymorphism in patients with systemic lupus erythematosus 70
Subclinical remodelling of draining lymph node structure in early and established rheumatoid arthritis assessed by power Doppler ultrasonography 69
B cells in rheumatoid arthritis. 69
Autoantibodies to heterogeneous nuclear ribonucleoproteins. 66
Long term treatment of rheumatoid arthritis with rituximab. 63
Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis 61
Long term treatment of rheumatoid arthritis with rituximab 60
Nuovi aspetti patogenetici dell’artrite reumatoide 60
CCL21 expression pattern of human secondary lymphoid organ stroma is conserved in inflammatory lesions with lymphoid neogenesis 60
Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment. 59
Analysis of the apolipoprotein(a) size polymorphism in patients with systemic lupus erythematosus. 59
What can we learn from treatment-induced changes in rheumatoid factor and anti-citrullinated peptide antibodies? 58
Analysis of the apolipoprotein(a) size polymorphism in patients with systemic lupus erythematosus 58
Subchondral Bone Marrow Inflammatory Involvement in Rheumatoid Arthritis: Lymphoid Neogenesis and In Situ Relationship with Subchondral Bone Marrow Osteoclasts 58
In early inflammatory polyarthritis more intensive management according to the 2010 ACR/EULAR criteria leads to higher rates of clinical remission: Comparison of two cohorts treated according to different treat to target protocols 57
Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis 57
Treatment comparison in rheumatoid arthritis: Head-to-head trials and innovative study designs 56
Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I. Efficacy 55
B cell autoimmunity and bone damage in rheumatoid arthritis 55
Involvement of subchondral bone marrow in rheumatoid arthritis: lymphoid neogenesis and in situ relationship to subchondral bone marrow osteoclast recruitment 54
Synovial tissue heterogeneity and peripheral blood biomarkers 53
B cell synovitis and clinical phenotypes in rheumatoid arthritis: relationship to disease stages and drug exposure 53
The draining lymph node in rheumatoid arthritis: current concepts and research perspectives 52
Clinical, Imaging, and Pathological Suppression of Synovitis in Rheumatoid Arthritis: Is the Disease Curable? 50
Correspondence on 'EULAR December 2020 viewpoints on SARS-CoV-2 vaccination in patients with RMDs' 50
Serum levels of CXCL13 are associated with ultrasonographic synovitis and predict power Doppler persistence in early rheumatoid arthritis treated with non-biological disease-modifying anti-rheumatic drugs 49
Modulating the co-stimulatory signal for T cell activation in rheumatoid arthritis: Could it be the first step of the treatment? 49
Early treatment in early undifferentiated arthritis 49
Reactogenicity, safety and disease flares following BNT162b2 mRNA COVID-19 vaccine in patients with chronic immune-inflammatory arthritis treated with biological and targeted synthetic disease-modifying anti-rheumatic drugs 49
Role of lymphoid chemokines in the development of functional ectopic lymphoid structures in rheumatic autoimmune diseases 46
What can we learn from treatment-induced changes in rheumatoid factor and anti-citrullinated peptide antibodies? 46
Rheumatoid arthritis treatment: the earlier the better to prevent joint damage 45
Long-term safety of abatacept in patients with rheumatoid arthritis 44
A Multicenter Retrospective Analysis Evaluating Performance of Synovial Biopsy Techniques in Patients With Inflammatory Arthritis: Arthroscopic Versus Ultrasound-Guided Versus Blind Needle Biopsy 44
The constitutive pattern of CCL21 production is maintained in inflammatory lesions with lymphoid neogenesis 44
Rheumatoid arthritis in beta-thalassemic trait: clinical, serologic and immunogenetic profile. 44
Seronegative autoimmune diseases: A challenging diagnosis 43
In patients with early peripheral psoriatic arthritis baseline c-reactive protein, pain and ultrasound-detected synovitis predict subsequent treatment with ts/bdmards. A retrospective analysis 43
B cell synovitis and clinical phenotypes in rheumatoid arthritis: relationship to disease stages and drug exposure 42
Challenges in the diagnosis of early rheumatoid arthritis in times of COVID-19 41
Early disease control by low-dose prednisone comedication may affect the quality of remission in patients with early rheumatoid arthritis. 40
Differences and similarities in rheumatology specialty training programmes across European countries 40
Impact of Anti-Citrullinated Protein Antibodies on Progressive Systemic Bone Mineral Density Loss in Patients With Early Rheumatoid Arthritis After Two Years of Treat-to-Target 40
Adult-onset Still's disease with elderly onset, results from a multicentre study 40
Polyarthrite rhumatoïde associée à un trait bêta-thalassémique : aspect clinique, sérologique et immunogénétique 38
La linfoneogenesi 38
Baseline Serum Concentrations of TRAIL in Early Rheumatoid Arthritis: Relationship with Response to Disease-modifying Antirheumatic Drugs. 38
Evaluation of Minimally Invasive, Ultrasound-guided Synovial Biopsy Techniques by the OMERACT Filter-Determining Validation Requirements 38
Power Doppler ultrasonographic assessment of the joint-draining lymph node complex in rheumatoid arthritis: a prospective, proof-of-concept study on treatment with tumor necrosis factor inhibitors. 36
The Clinical Value of Autoantibodies in Rheumatoid Arthritis. 36
Established rheumatoid arthritis. The pathogenic aspects. 36
A “Window of Therapeutic Opportunity” for Anti-Cytokine Therapy in Patients With Coronavirus Disease 2019 36
Limiting factors to Boolean remission differ between autoantibody-positive and -negative patients in early rheumatoid arthritis 35
Golimumab effectiveness in biologic inadequate responding patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis in real-life from the Italian registry GISEA 34
Personalized Therapeutic Strategies in the Management of Osteoporosis in Patients with Autoantibody-Positive Rheumatoid Arthritis 34
Inflammatory correlates of the Patient Global Assessment of Disease Activity vary in relation to disease duration and autoantibody status in patients with rheumatoid arthritis 33
The novel cytokine interleukin-36α is expressed in psoriatic and rheumatoid arthritis synovium 33
Over-expression of miR-223 in T-lymphocytes of early rheumatoid arthritis patients 33
Clinical Applications of Synovial Biopsy. 33
Cytokine profile, ferritin, and multi-visceral involvement characterise macrophage activation syndrome during adult-onset Still's disease 33
Use of ultrasound-guided small joint biopsy to evaluate the histopathologic response to rheumatoid arthritis therapy: recommendations for application to clinical trials 32
Dupilumab-induced enthesoarthritis and refractory atopic dermatitis successfully treated with baricitinib 32
High expression levels of the B cell chemoattractant CXCL13 in rheumatoid synovium are a marker of severe disease 32
Increasing the threshold for patient global assessment in defining remission may have a different impact in patients with early and established rheumatoid arthritis 32
No evidence of short-term impact of repeated BNT162b2 vaccination on rheumatoid arthritis homeostasis in drug-free remission 31
Vitamin D 25OH Deficiency and Mortality in Moderate to Severe COVID-19: A Multi-Center Prospective Observational Study 31
Insights Into the Concept of Rheumatoid Arthritis Flare 31
Progressive increase in time to referral and persistently severe clinical presentation over the years in autoantibody-negative patients with rheumatoid arthritis in the setting of an early arthritis clinic 30
Controversies over hydroxychloroquine in the prevention of SARS-CoV-2 infection put rheumatologists on the frontline 29
Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group 29
Rheumatology training experience across Europe: Analysis of core competences 25
Histopathology of the synovial tissue: Perspectives for biomarker development in chronic inflammatory arthritides. 25
Inflammatory lesions in the bone marrow of rheumatoid arthritis patients: a morphological perspective 25
Transient monoarthritis and psoriatic skin lesions following COVID-19 22
A case of a rheumatoid nodule on the aortic valve in a patient with rheumatoid arthritis in sustained remission with anti-TNFα 21
Impact of corticosteroids and immunosuppressive therapies on symptomatic SARS-CoV-2 infection in a large cohort of patients with chronic inflammatory arthritis 21
Correction to: Management of adult-onset Still's disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts 20
Synovial and serum B-cell signature of autoantibody-negative rheumatoid arthritis versus autoantibody-positive rheumatoid arthritis and psoriatic arthritis 19
Cost-effectiveness of the early arthritis clinic organizational model: the ELECTRA study 19
Anti-neutrophil cytoplasmic antibodies (ANCA) 19
null 18
Do we need Early Arthritis Clinics to counteract the excess of mortality in rheumatoid arthritis? 18
Seronegative rheumatoid arthritis: one year in review 2023 16
Retention rate of a second line with a biologic DMARD after failure of a first-line therapy with abatacept, tocilizumab, or rituximab: results from the Italian GISEA registry 16
Tumor necrosis factor-α inhibitor-related autoimmune disorders 15
Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial 15
The access route through the anatomical snuffbox in ultrasound-guided synovial biopsy of the wrist allows for a safe and effective collection of tissue samples in inflammatory arthritis 14
Increased COVID-19 mortality in patients with rheumatic diseases: results from the CONTROL-19 study by the Italian Society for Rheumatology 13
The Genetic, Environmental, and Immunopathological Complexity of Autoantibody-Negative Rheumatoid Arthritis 12
Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial 11
High serum levels of CXCL13 predict lower response to csDMARDs in both ACPA-positive and ACPA-negative early rheumatoid arthritis 10
Administrative Databases and Diagnostic Therapeutic and Assistance Paths -PDTA- in the Monitoring Treatment of Rheumatoid Arthritis: The Experience of ATS Pavia 10
Clinical Features of Diabetes Mellitus on Rheumatoid Arthritis: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group 9
Comorbidities in the Spondyloarthritis GISEA Cohort: an average treatment effect analysis on patients treated with bDMARDs 8
Totale 4.058
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.128
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.128
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020126 0 0 0 0 0 0 4 31 10 37 40 4
2020/2021283 28 21 10 25 0 31 8 51 16 45 37 11
2021/2022362 4 3 12 14 10 26 15 23 19 8 54 174
2022/20231.352 143 103 11 86 104 126 1 72 529 20 50 107
2023/2024626 46 182 22 30 53 149 23 34 11 12 31 33
2024/2025336 43 111 24 24 21 110 3 0 0 0 0 0
Totale 4.089